These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24291014)

  • 1. Effect of tissue plasminogen activator dose and interval on stroke severity.
    Nedelman CB; Glenn LL
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):197-8. PubMed ID: 24291014
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "Effect of tissue plasminogen activator dose and interval on stroke severity".
    Sahlas DJ; Gould L; Swartz R; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):198. PubMed ID: 24291015
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric oro-facial angioedema following alteplase for acute ischaemic stroke.
    Wu TY; Wei DY; Baker Y; Sharkey B; Frith RW
    J Clin Neurosci; 2014 Nov; 21(11):2004-6. PubMed ID: 24974191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischaemic stroke: decide rapidly.
    Prescrire Int; 2015 Sep; 24(163):221. PubMed ID: 26417638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some suggest wider therapeutic window for offering alteplase to treat stroke.
    Mitka M
    JAMA; 2010 Jul; 304(2):146. PubMed ID: 20628121
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW
    Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Decision Making: Hyposphagma Prior to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.
    Newey CR; Cueva W; Vellipuram A; Hornik A
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e181-2. PubMed ID: 27492945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis.
    Kamal H; Mowla A; Farooq S; Shirani P
    J Neurol Sci; 2015 Nov; 358(1-2):496-7. PubMed ID: 26375625
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous thrombolysis in patients older than age 80 years.
    Longstreth WT; Tirschwell DL
    Stroke; 2010 Oct; 41(10):e580; author reply e581. PubMed ID: 20798362
    [No Abstract]   [Full Text] [Related]  

  • 15. IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon?
    Barrett KM; Gottesman RF
    Neurology; 2016 Jul; 87(2):132-3. PubMed ID: 27306635
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis in dementia patients with acute stroke: is it justified?
    Paciaroni M; Pantoni L
    Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke.
    Yip TR; Demaerschalk BM
    Neurocrit Care; 2005; 2(1):47-8. PubMed ID: 16174968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a medicolegal approach in clinical stalemates.
    Tang M
    J Med Ethics; 2012 Nov; 38(11):645-6. PubMed ID: 22923440
    [No Abstract]   [Full Text] [Related]  

  • 19. SITS-MOST: old myths laid to rest.
    Hallevi H; Grotta JC
    Lancet Neurol; 2007 Apr; 6(4):292-3. PubMed ID: 17362829
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
    Strbian D; Saposnik G
    Stroke; 2016 Dec; 47(12):3063-3064. PubMed ID: 27789665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.